Morphine is protective against doxorubicin-induced cardiotoxicity in rat
Authors:
- Shahram EjtemaeemehrSEShahram Ejtemaeemehr
- Seyed Mohammad TavangarSTSeyed Mohammad Tavangar
- Reza RahimianRRReza Rahimian
- Jalal Izadi MobarakehJMJalal Izadi Mobarakeh
- Ahmad Reza DehpourADAhmad Reza Dehpour
- 1 January 2008
- journal article
- Published by Elsevier in Toxicology
- Vol. 243 (1-2) , 96-104
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Persistent Effects of Doxorubicin on Cardiac Gene ExpressionJournal of Molecular and Cellular Cardiology, 1999
- QT dispersion and late potentials during doxorubicin therapy for non‐Hodgkin’s lymphomaJournal of Internal Medicine, 1999
- Contractile Failure in Chronic Doxorubicin-induced CardiomyopathyJournal of Molecular and Cellular Cardiology, 1997
- Lithium attenuates the effects of dynorphin A(1–13) on inositol 1,4,5-trisphosphate and intracellular CA2+ in rat ventricular myocytesLife Sciences, 1996
- Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin AdministrationToxicology and Applied Pharmacology, 1994
- Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heartJACC, 1994
- Electrocardiographic changes and arrhythmias after cancer therapy in children and young adultsThe American Journal of Cardiology, 1992
- Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the ratToxicology and Applied Pharmacology, 1990
- Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the ratJournal of Pharmacological Methods, 1986
- Doxorubicin Cardiotoxicity in the RatJournal of Cardiovascular Pharmacology, 1984